Frequency Therapeutics, Inc. (33)
Browse by Contract Category
Contracts
-
Sublease Agreement, dated July 8, 2022, by and between Frequency Therapeutics, Inc. and Saliogen Therapeutics, Inc
(Filed With SEC on July 12, 2022)
-
Employment Agreement, dated as of November 25, 2020, by and between Frequency Therapeutics, Inc. and Quentin McCubbin
(Filed With SEC on May 4, 2022)
-
Letter Agreement, dated April 15, 2022, by and between Frequency Therapeutics, Inc. and Wendy Arnold
(Filed With SEC on April 15, 2022)
-
Exclusive Patent License Agreement, dated as of December 13, 2016, as amended, between Massachusetts Institute of Technology and Frequency Therapeutics, Inc
(Filed With SEC on March 15, 2022)
-
Equity Distribution Agreement, dated as of December 10, 2021, between Frequency Therapeutics, Inc. and Oppenheimer & Co. Inc
(Filed With SEC on December 10, 2021)
-
Form of Indemnification Agreement for Directors and Officers
(Filed With SEC on September 23, 2019)
-
Letter Agreement, dated April 15, 2022, by and between Frequency Therapeutics, Inc. and Richard Mitrano
(Filed With SEC on April 15, 2022)
-
Separation Agreement, dated as of March 31, 2022, by and between Frequency Therapeutics, Inc. and Peter P. Pfreundschuh
(Filed With SEC on March 31, 2022)
-
Employment Agreement, effective February 3, 2020, by and between Frequency Therapeutics, Inc. and Wendy S. Arnold
(Filed With SEC on March 29, 2021)
-
Agreement for Termination of Lease and Voluntary Surrender of Premises, dated December 11, 2020, by and between Frequency Therapeutics, Inc. and ARE-MA-Region No. 20, LLC
(Filed With SEC on December 16, 2020)
-
Loan and Security Agreement, dated December 11, 2020, by and between Frequency Therapeutics, Inc. and Silicon Valley Bank
(Filed With SEC on December 15, 2020)
-
Employment Agreement, effective December 1, 2020, by and between Frequency Therapeutics, Inc. and Peter P. Pfreundschuh
(Filed With SEC on December 1, 2020)
-
Registration Rights Agreement, dated July 17, 2020, by and among Frequency Therapeutics, Inc. and the Investors named therein
(Filed With SEC on July 21, 2020)
-
Securities Purchase Agreement, dated July 17, 2020, by and among Frequency Therapeutics, Inc. and the Investors named therein
(Filed With SEC on July 21, 2020)
-
Lease Agreement, dated as of August 24, 2016, as amended, between ARE-MA Region No. 20 and Frequency Therapeutics, Inc
(Filed With SEC on March 26, 2020)
-
Indenture of Lease, effective as of January 7, 2020 between HCP/KING 75 Hayden LLC and Frequency Therapeutics, Inc
(Filed With SEC on March 26, 2020)
-
Description of Frequency Therapeutics, Inc. Securities
(Filed With SEC on March 26, 2020)
-
Form of Specimen Common Stock Certificate
(Filed With SEC on September 23, 2019)
-
Employment Agreement, dated as of September 19, 2019, between Carl P. LeBel and the Registrant
(Filed With SEC on September 23, 2019)
-
2019 Incentive Award Plan and form of option agreements thereunder
(Filed With SEC on September 23, 2019)
-
Non-Employee Director Compensation Program
(Filed With SEC on September 23, 2019)
-
Lease Agreement, effective as of August 1, 2019 between the University of Connecticut and the Registrant
(Filed With SEC on September 23, 2019)
-
Second Amended and Restated Executive Employment Agreement, dated as of September 20, 2019, between David L. Lucchino and the Registrant
(Filed With SEC on September 23, 2019)
-
Amended and Restated Employment Agreement, dated as of September 20, 2019, between Christopher R. Loose and the Registrant
(Filed With SEC on September 23, 2019)
-
2019 Employee Stock Purchase Plan
(Filed With SEC on September 23, 2019)
-
Form of Underwriting Agreement
(Filed With SEC on September 23, 2019)
-
Lease Agreement, dated as of August 24, 2016, between ARE-MA Region No. 20 and the Registrant
(Filed With SEC on September 6, 2019)
-
Second Amended and Restated Investors Rights Agreement, dated as of July 17, 2019, by and among the Registrant and the investors party thereto
(Filed With SEC on September 6, 2019)
-
2014 Stock Incentive Plan, as amended, and form of option agreements thereunder
(Filed With SEC on September 6, 2019)
-
Form of Founder Restricted Stock Agreement
(Filed With SEC on September 6, 2019)
-
Exclusive Patent License Agreement, dated as of December 13, 2016, as amended, between Massachusetts Institute of Technology and the Registrant
(Filed With SEC on September 6, 2019)
-
Non-Exclusive Patent License Agreement, dated as of February 7, 2019, between Massachusetts Eye and Ear Infirmary and the Registrant
(Filed With SEC on September 6, 2019)
-
License and Collaboration Agreement, dated as of July 16, 2019, between Astellas Pharma, Inc. and the Registrant
(Filed With SEC on September 6, 2019)